Colgate-Palmolive (CL) Receives $67.14 Average Target Price from Analysts

Colgate-Palmolive (NYSE:CL) has earned an average recommendation of “Hold” from the seventeen research firms that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $67.14.

CL has been the topic of a number of research analyst reports. Zacks Investment Research cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Monday, October 29th. Argus restated a “buy” rating and issued a $75.00 price target (up previously from $72.00) on shares of Colgate-Palmolive in a research note on Tuesday, September 18th. Citigroup dropped their price target on Colgate-Palmolive from $68.00 to $63.00 and set a “hold” rating on the stock in a research note on Monday, October 29th. Wells Fargo & Co dropped their price target on Colgate-Palmolive from $62.00 to $58.00 and set a “market perform” rating on the stock in a research note on Monday, October 29th. Finally, SunTrust Banks cut Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price target for the company from $80.00 to $65.00 in a research note on Friday, October 26th.

CL traded down $0.52 during trading hours on Monday, reaching $62.71. The company’s stock had a trading volume of 4,072,657 shares, compared to its average volume of 4,488,039. Colgate-Palmolive has a 52 week low of $57.41 and a 52 week high of $77.91. The company has a current ratio of 1.11, a quick ratio of 0.77 and a debt-to-equity ratio of 64.85. The stock has a market cap of $54.84 billion, a PE ratio of 21.85, a price-to-earnings-growth ratio of 3.11 and a beta of 0.76.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 26th. The company reported $0.72 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a return on equity of 12,004.60% and a net margin of 13.55%. The business had revenue of $3.85 billion for the quarter, compared to analysts’ expectations of $3.89 billion. During the same quarter in the prior year, the business earned $0.73 EPS. The firm’s revenue for the quarter was down 3.2% on a year-over-year basis. Equities analysts forecast that Colgate-Palmolive will post 2.96 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, November 15th. Shareholders of record on Friday, October 19th were issued a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a yield of 2.68%. The ex-dividend date was Thursday, October 18th. Colgate-Palmolive’s dividend payout ratio is 58.54%.

In other news, VP Philip G. Shotts sold 462 shares of the stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total transaction of $30,977.10. Following the sale, the vice president now directly owns 41,250 shares of the company’s stock, valued at approximately $2,765,812.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Henning I. Jakobsen sold 1,015 shares of the stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total value of $68,055.75. Following the sale, the chief financial officer now directly owns 36,193 shares in the company, valued at $2,426,740.65. The disclosure for this sale can be found here. Corporate insiders own 1.02% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Rehmann Capital Advisory Group grew its holdings in shares of Colgate-Palmolive by 15.3% during the 3rd quarter. Rehmann Capital Advisory Group now owns 2,830 shares of the company’s stock worth $190,000 after purchasing an additional 375 shares in the last quarter. Marshall Wace North America L.P. grew its holdings in shares of Colgate-Palmolive by 17.0% during the 3rd quarter. Marshall Wace North America L.P. now owns 58,709 shares of the company’s stock worth $3,931,000 after purchasing an additional 8,511 shares in the last quarter. Matthew Goff Investment Advisor LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter worth $303,000. Great Lakes Advisors LLC grew its holdings in shares of Colgate-Palmolive by 795.0% during the 3rd quarter. Great Lakes Advisors LLC now owns 77,893 shares of the company’s stock worth $5,215,000 after purchasing an additional 69,190 shares in the last quarter. Finally, Carnegie Capital Asset Management LLC grew its holdings in shares of Colgate-Palmolive by 94.1% during the 3rd quarter. Carnegie Capital Asset Management LLC now owns 56,214 shares of the company’s stock worth $3,556,000 after purchasing an additional 27,250 shares in the last quarter. 75.10% of the stock is currently owned by institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Recommended Story: Cost of equity and a company’s balance sheet

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply